Michele De Tursi

9PUBLICATIONS
109CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 13, 2025
Low Phosphatidylserine+ Cells Within the CD34+/CD45dim/CD117(c-kit)+ Subpopulation Are Associated with Poor Outcomes in Metastatic Colorectal Cancer.

Davide Brocco, Pasquale Simeone, Pietro Di Marino

|May 01, 2023
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer.

Alessio Cortellini, Antonio D'Alessio, Siobhan Cleary

|Apr 12, 2023
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study.

Luca Cantini, Francesco Paoloni, Federica Pecci

|Nov 26, 2022
Conversion Strategy in Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer Patients with Unresectable Liver-Limited Disease: A Multicenter Cohort Study.

Stefano Granieri, Christian Cotsoglou, Alessandro Bonomi

|Oct 14, 2022
High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Patients with Pancreatic Cancer: Results from a Multicenter Prospective Study.

Davide Brocco, Domenico De Bellis, Pietro Di Marino

|Apr 18, 2022
Pancytopenia During Osimertinib Treatment in a Patient with EGFR-Mutated Non-Small Cell Lung Cancer.

Pietro Di Marino, Cosima Chiapperino, Francesca Chiara Primavera

Pageof 2

Frequent Collaborators

5 joint publications

Nicola Tinari

4 joint publications

Michele Ghidini

3 joint publications

Davide Brocco

3 joint publications

Alessio Cortellini